Pathophysiological mechanisms of parvovirus B19 infection

about

Cellular immune mechanisms in myocarditis.

P2860

Q40076595-FFC49848-0E4F-489A-8EF7-8E043F227AB4

P2860

Pathophysiological mechanisms of parvovirus B19 infection

Item

http://www.wikidata.org/entity/Q42789700

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Pathophysiological mechanisms of parvovirus B19 infection

@en

Pathophysiological mechanisms of parvovirus B19 infection

@nl

type

Item

label

Pathophysiological mechanisms of parvovirus B19 infection

@en

Pathophysiological mechanisms of parvovirus B19 infection

@nl

prefLabel

Pathophysiological mechanisms of parvovirus B19 infection

@en

Pathophysiological mechanisms of parvovirus B19 infection

@nl

P1476

Pathophysiological mechanisms of parvovirus B19 infection

@en

P2093

Bernhard Maisch

http://www.w3.org/2001/XMLSchema#string

Sabine Pankuweit

http://www.w3.org/2001/XMLSchema#string

P2860

Prolonged activation of virus-specific CD8+T cells after acute B19 infection.

NS1 specific CD8+ T-cells with effector function and TRBV11 dominance in a patient with parvovirus B19 associated inflammatory cardiomyopathy.

High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction.

High prevalence of human parvovirus B19 DNA in myocardial autopsy samples from subjects without myocarditis or dilative cardiomyopathy.

Parvovirus B19 infection mimicking acute myocardial infarction.

A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis.

Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders.

Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction.

The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID). First epidemiological results.

Prevalence of erythrovirus genotypes in the myocardium of patients with dilated cardiomyopathy.

P304

2358-9; author reply 2359

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.00580-09

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michel Noutsias

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19574588

http://www.w3.org/2001/XMLSchema#string

P921

pathophysiology

P932

2708529

http://www.w3.org/2001/XMLSchema#string

Pathophysiological mechanisms of parvovirus B19 infection

about

P2860

P2860

Pathophysiological mechanisms of parvovirus B19 infection

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932